Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
Provided By GlobeNewswire
Last update: Jan 27, 2025
- High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of Alpha DaRT® -
Read more at globenewswire.comNASDAQ:DRTSW (11/4/2025, 8:18:40 PM)
0.2999
-0.02 (-6.28%)
NASDAQ:DRTS (11/4/2025, 8:18:40 PM)
3.87
-0.05 (-1.28%)
Find more stocks in the Stock Screener
